Genmab — Maj 2020

kkjoel

and hungry maybe...

kkjoel

Åh nej, det hedder: super hungry

E_L

@Bulder it seems he already knows what the next epco
trial will look like...

Solsen

Its a good option on cami-t. I think the antibody conjugate are much better than SGENs Adcetris, which sold for $164 mln in Q120 in north america. BUT safety could be an issue.

Sukkeralf

there have been a lot of focus on next generation BTK inhibitors - if ot not with ibrutinib then maybe one of those

Solsen

JW was clever not to disclose which small molecule he preferred

Solsen

Yes sukker its crowded.

Sukkeralf

The warheads on ADCT´s ADCs are much more potent but as you say safety is the big issue. Ohad Hammer did not like ADCTs their approch

Solsen

Thats the reason Iam not sure about the future. But again here Genmab was wise not to put more money in something that could be too toxic.

E_L

i am curious now on "Genmab's next generation AB technologies for making better COVID-19 antibody therapeutics.."

E_L

i don't want to read too much into it, but curious

Solsen

Very interesting that Genmab are involved. But I think its all over before they are able to have anything ready.

nohope

I sure don´t hope it is Genmab with AB who is going to save us from

nohope

Covid-19

nohope

Would be great if they could pick something as a generalist against vira for the future pandemics - but Covid-19 should be gone long time before.

nohope

Something that could control the cytokinstorm.

kkjoel

Sidder her med tilbageholdt åndedræt.. det man har venter på i nogle år sker for øjnene af en. En art
déjà vu

Solsen

Mon vi kan lukke i 1900. Så er der kun en dag til 2000 ;-). Hvis vi kan holde tempoet ,,,

kkjoel

Helge - kan godt se mit spørgsmål vedr. vigtigheden af US market var marginalt ift. de andre mere essentielle antistof-teknologi spørgsmål... håber dog du får plads til at stille det næste gang.. måske ovenpå en deal

kkjoel

Ja, vi er - faretruende vel, i nohopes øjne - tæt på 1900 Noget MÅ vi da kunne ikke-håbe på!